Abacus Global Management 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Abacus Global Management reported 3rd quarter 2026 revenue of $76.9 million, up 22% year over year, and adjusted net income of $29.4 million, up 24%, or adjusted EPS of $0.29.
- Adjusted EBITDA was $42.3 million, with a 55% margin, and adjusted return on equity was 26%, up 440 basis points year over year.
- Life Solutions revenue was $71.3 million, up 32% from $54.1 million a year ago; technology services revenue was $0.6 million, up 155% from $0.2 million.
- Realized gains on policies sold and matured rose by $25.8 million year over year, more than offsetting an $11.1 million decline in unrealized gains.
- Abacus deployed $235.3 million of capital in the quarter and $596.8 million year to date, up 71% compared to its 2025 pace; quarterly policy reviews totaled 17,787.
- Longevity fund inflows were approximately $452.4 million in the 3rd quarter, and $997 million through the 3rd quarter, compared to $604 million for all of 2025.
- Cash held at quarter end was $104 million, policy assets were $370 million, and long-term debt excluding non-recourse liabilities was $366 million.
- Abacus repurchased $1.7 million of ABX stock at an average share price of $8.13 and announced a 10% increase in its regular annual dividend to $0.22 per share, with an ex-dividend date of December 1st, 2026.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Please note this event is being recorded. I would like to now turn the call over to David Jackson, Abacus Global Management Head of Investor Relations.
Please go ahead. Thank you, operator, and thank you, everyone, for joining Abacus Global Management's third quarter earnings call.
Here with me today are Jay Jackson, Chairman and Chief Executive Officer, Elena Plesco, Chief Investment Officer, and Bill McCauley, Chief Financial and Chief Operating Officer. This afternoon at 4:05 P.M. Eastern Time, Abacus Global Management released our third quarter 2026 results. This afternoon's call will allow participants to ask questions about our results. Before we begin, Abacus Global Management refers participants on this call to the investor webpage, ir.abacusgm.com, for the press release, investor information, and filings with the SEC for discussion of the risks that can affect the business.
Abacus Global Management more specifically refers participants to the presentation furnished today on Form 8-K with the Securities and Exchange Commission and reminds listeners that some of the comments today may contain forward-looking statements, and as such, will be subject to risks and uncertainties which, if they materialize, could materially affect results. For more information on the risks, uncertainties, and assumptions relating to forward-looking statements, please refer to Abacus Global Management's public filings. During the call, we will reference certain non-GAAP financial measures. Although we believe these measures provide useful supplemental information about our financial performance, they are not recognized measures and do not have standardized meanings under U.S. Generally Accepted Accounting Principles, or GAAP. Please see our public filings for additional information regarding our non-GAAP financial measures, including references to comparable GAAP measures.
With that, I would now like to turn the call over to Jay Jackson, Abacus Global Management's Chairman and Chief Executive Officer.
Thank you, David, and thank you all for joining us today. The third quarter was a momentous one for Abacus. We outperformed operationally and made meaningful strategic progress. In the third quarter alone, we hosted our investor day at the New York Stock Exchange, launched the ABX Longevity Growth and Income Fund, and completed our largest securitization to date. Most recently, we broadened LifeARC's reach through our partnership with Retirable and its network of RIAs, alongside Manning & Napier. Let me start with a few key metrics that Bill and Elena will detail later. Through the third quarter, longevity fund inflows were $997 million, compared to $604 million for all of 2025. We also continue to see strong demand for our assets from outside buyers, and our earnings continue to convert to cash.
Over the last 12 months, cash EBITDA was $203.2 million, or 132% of adjusted EBITDA, as gains we recorded in prior periods converted to cash faster than we added new ones. The gains we book are showing up as cash, and that is strong support for how we value our book. This quarter, two of our funds, accounting for over $1 billion in AUM, sold 27% of their portfolios to investors above NAV. This is independent buyers paying more than the values we carry, which is the strongest check we have on our marks. The story I most want you to take away from this quarter is LifeARC. Over the coming decades, an estimated $124 trillion will pass from one generation to the next in the U.S. Nearly every financial plan behind that wealth still answers its most important question with a guess: How long will I live?
A lifespan is an arc of probabilities, and LifeARC is the first platform built to measure that arc for an individual. It takes the proprietary longevity data and HIPAA-compliant medical insight we have spent more than 20 years building for institutional markets and puts it in the hands of individual investors and the advisors who serve them. That is what puts Abacus at the center of how this wealth transfer will be planned and managed. We are still early, but the first signals are striking. LifeARC has generated 357 inquiries to date. In the first week of our new client pipeline alone, inquiries represented roughly $43 million of combined investable assets, an average of about $7 million per inquiry, with the largest at $20 million. To date, the pipeline has included over $500 million in investable assets.
The people who are coming to LifeARC are exactly who we built it for. 91% are age 50 plus, with an average of 66, and 100% opted to be contacted. The tools are what we designed them to do. Six of the first seven pipeline inquiries came through our lifespan calculator, and we have already seen our first referral flow from abacusgm.com into LifeARC. Two partner firms, Retirable and Manning & Napier, are now live and enrolling clients into LifeARC investment portfolios. Since our October 13th partnership announcement, LifeARC holds the number one Google position for its name, and branded search clicks rose fivefold in a single week. On the funding side, our last securitization closed in September at more than $400 million in total structure. It is our largest securitization to date and roughly eight times the size of our inaugural note just a year ago.
The investment-grade rated notes were placed primarily with insurance companies. The deal was two times oversubscribed, which allowed us to upsize it. As a part of a rated transaction, the assets were stress-tested and reviewed by well-known institutional financial sponsors and multi-hundred-billion-dollar insurance companies. We view this as market validation and as a meaningful new arrow in the quiver. Securitization further diversifies our distribution channels and gives us a cost of capital advantage and greater efficiency as we scale. While we are not providing a dollar-denominated target, we expect to pursue two to three securitizations per year, with the next currently planned for the first quarter of 2027. This quarter showed what Abacus is becoming, a platform where more than 20 years of longevity data powers institutional capital markets on one side and individual financial planning on the other.
We remain highly confident this momentum can continue in the quarters and years ahead. With that, let me turn the call over to Bill to review our quarterly financials.
Thank you, Jay. As I have in quarters past, I'll start with our outlook and then walk through our operational and financial performance. Third quarter adjusted net income of $29.4 million came in above the top end of the $26 million-$28 million range we guided to last quarter. Based on that strong performance, we are raising our full year 2026 guidance for the second time this year. We now expect adjusted net income of $104.5 million-$106.5 million, up from $100 million-$106 million, and adjusted EPS of $1.05-$1.07, up from $1.00-$1.05. At the top end, that represents 24% growth over 2025.
For the fourth quarter, we expect adjusted net income of $28 million-$30 million, or adjusted EPS of $0.28-$0.30, which at the top end represents 30% growth over the fourth quarter of 2025. As a reminder, our adjusted net income guidance is presented on a gross basis before estimated tax effects. Jay said it well. Our momentum remains strong at Abacus across an increasing range of value creation opportunities. In the third quarter, we deployed $235.3 million of capital, which brings our year-to-date total to $596.8 million, up 71% compared to our 2025 pace. In Q3, we reviewed 17,787 qualified policies, and year to date, the total number of policies reviewed has surpassed 101,000. Similar to our comments last quarter, Abacus continues to improve inbound volume through the top of the funnel and has also enhanced screening and underwriting efficiency through technology and AI.
Demand was also strong in our longevity fund products, with capital inflows totaling approximately $452.4 million in the third quarter, which is more than six times the rate of the prior year period. Turning to our financial results, Abacus generated revenue of $76.9 million for the third quarter, an increase of 22% year over year. That growth was driven by Life Solutions revenue of $71.3 million, up 32% from $54.1 million a year ago, and technology services revenue of $0.6 million, up 155% from $0.2 million a year ago. In the Life Solutions segment, growth was driven by strong performance on life settlement policies sold. Specifically, realized gains on policies sold and matured rose by $25.8 million year over year, more than offsetting an $11.1 million decline in unrealized gains.
Abacus also generated strong growth in both insurance commissions and on originations, which were up 145.5% and 281.9% respectively compared to a year ago. Operating expenses for the third quarter totaled $43.4 million, driven by general and administrative expenses of $33.6 million, up from $24.7 million, and sales and marketing expense of $5.6 million, up from $3.8 million. The 32% increase in total operating expenses was largely driven by higher legal and professional fees. General and administrative expenses rose $8.9 million, primarily reflecting $5.2 million of higher legal and professional fees incurred in connection with various strategic projects, and $1.8 million of higher payroll from staffing added through acquisitions, while sales and marketing rose $1.8 million on higher advertising to support Life Solutions growth. Adjusted EBITDA in the quarter of $42.3 million, representing a margin of 55%, which remains very strong despite the increase in professional fees I just mentioned.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
12 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
